The breast tumor microenvironment: role in cancer development, progression and response to therapy

被引:142
作者
Mittal, Suruchi [1 ]
Brown, Nicola J. [1 ]
Holen, Ingunn [1 ]
机构
[1] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England
关键词
Breast cancer; bone; microenvironment; bone metastases; bone targeted agents; REGULATORY T-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; NEUTROPHIL-LYMPHOCYTE RATIO; MAMMARY-GLAND DEVELOPMENT; EXTRACELLULAR-MATRIX; MAMMOGRAPHIC DENSITY; TGF-BETA; INFILTRATING LYMPHOCYTES; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS;
D O I
10.1080/14737159.2018.1439382
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Numerous clinical and pre-clinical studies have provided ample evidence supporting that the tumor microenvironment plays a significant role during breast cancer development, progression and in determining the therapeutic response.Areas covered: This review focuses on the evolving concept of the microenvironment as the critical participant in each step of the multi-stage process of malignant progression. Currently, only a small number of molecules form part of routine molecular diagnostics in breast caner, but microenvironment-derived biomarkers are potential additions to existing predictive and prognostic marker panels. The authors discuss the dependency of the breast tumor cells on different components of the microenvironment for their survival, dissemination, dormancy and establishment in secondary sites to form overt metastasis, as well as the potential as a therapeutic target to improve breast cancer outcome.Expert commentary: Despite the importance in the development of breast cancer, the contribution of the microenvironment is not considered in routine diagnostic testing or informing therapeutic decisions. However, introduction of immunotherapy will increasingly require patient selection based on the stromal composition of the primary breast tumor. Better understanding of the role of specific microenvironment-derived molecules is likely to inform personalized therapy, leading to improved patient outcome.
引用
收藏
页码:227 / 243
页数:17
相关论文
共 246 条
[1]   Anti-angiogenic treatment in breast cancer: Facts, successes, failures and future perspectives [J].
Aalders, Kim C. ;
Tryfonidis, Konstantinos ;
Senkus, Elbieta ;
Cardoso, Fatima .
CANCER TREATMENT REVIEWS, 2017, 53 :98-110
[2]   Bone health management in patients with breast cancer: Current standards and emerging strategies [J].
Aapro, Matti S. ;
Coleman, Robert E. .
BREAST, 2012, 21 (01) :8-19
[3]   Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration [J].
Acerbi, I. ;
Cassereau, L. ;
Dean, I. ;
Shi, Q. ;
Au, A. ;
Park, C. ;
Chen, Y. Y. ;
Liphardt, J. ;
Hwang, E. S. ;
Weaver, V. M. .
INTEGRATIVE BIOLOGY, 2015, 7 (10) :1120-1134
[4]   EFFECTS OF HUMAN-BREAST FIBROBLASTS ON GROWTH AND 17-BETA-ESTRADIOL DEHYDROGENASE-ACTIVITY OF MCF-7 CELLS IN CULTURE [J].
ADAMS, EF ;
NEWTON, CJ ;
BRAUNSBERG, H ;
SHAIKH, N ;
GHILCHIK, M ;
JAMES, VHT .
BREAST CANCER RESEARCH AND TREATMENT, 1988, 11 (02) :165-172
[5]   Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 [J].
Adams, Sylvia ;
Gray, Robert J. ;
Demaria, Sandra ;
Goldstein, Lori ;
Perez, Edith A. ;
Shulman, Lawrence N. ;
Martino, Silvana ;
Wang, Molin ;
Jones, Vicky E. ;
Saphner, Thomas J. ;
Wolff, Antonio C. ;
Wood, William C. ;
Davidson, Nancy E. ;
Sledge, George W. ;
Sparano, Joseph A. ;
Badve, Sunil S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2959-+
[6]  
Al-Raawi D, 2011, INT J CLIN EXP MED, V4, P265
[7]   Characterization of single circulating tumor cells [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
FEBS LETTERS, 2017, 591 (15) :2241-2250
[8]   Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion [J].
Allen, Michael D. ;
Vaziri, Reza ;
Green, Michael ;
Chelala, Claude ;
Brentnall, Adam R. ;
Dreger, Sally ;
Vallath, Sabarinath ;
Nitch-Smith, Harriet ;
Hayward, Jane ;
Carpenter, Robert ;
Holliday, Deborah L. ;
Walker, Rosemary A. ;
Hart, Ian R. ;
Jones, J. Louise .
JOURNAL OF PATHOLOGY, 2011, 223 (05) :646-658
[9]   Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins [J].
Alonso-Escolano, D ;
Strongin, AY ;
Chung, AW ;
Deryugina, EI ;
Radomski, MW .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (02) :241-252
[10]   Protein kinase Cδ mediates platelet-induced breast cancer cell invasion [J].
Alonso-Escolano, David ;
Medina, Carlos ;
Cieslik, Katarzyna ;
Radomski, Anna ;
Jurasz, Paul ;
Santos-Martinez, Maria Jose ;
Jiffar, Tilahum ;
Ruvolo, Peter ;
Radomski, Marek W. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (01) :373-380